SCHEMBL20101049

SCHEMBL20101049

c1c(N2CCOCC2)ncc2sc(N3CCOCC3)nc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 12/20 0.59
RAB9A P51151 12/20 0.59
NPC1 O15118 10/20 0.59
MAPT P10636 9/20 0.59
TP53 P04637 4/20 0.59
USP2 O75604 3/20 0.59
PKM P14618 1/20 0.59
HPGD P15428 5/20 0.58
ALDH1A1 P00352 5/20 0.58
HSD17B10 Q99714 4/20 0.58
GAA P10253 3/20 0.58
ALOX15 P16050 3/20 0.58
TSHR P16473 2/20 0.58
AR P10275 1/20 0.55
HTT P42858 1/20 0.46
MAPK1 P28482 1/20 0.46
LMNA P02545 2/20 0.44
IRAK1 P51617 1/20 0.41
IRAK4 Q9NWZ3 1/20 0.41
CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24330005 0.84 RAB9A (0.58) SMN1; SMN2RAB9ANPC1MAPTTP53
SCHEMBL9963514 0.81 RAB9A (0.74) SMN1; SMN2RAB9ANPC1MAPTTP53
SCHEMBL20101017 0.81 NPC1 (0.48) SMN1; SMN2RAB9ANPC1MAPTTP53
SCHEMBL30611157 0.78 LRRK2 (0.46) SMN1; SMN2RAB9ANPC1MAPTTP53
SCHEMBL30611161 0.78 CYP2D6 (0.46) SMN1; SMN2RAB9ANPC1MAPTTP53
SCHEMBL24330007 0.78 CYP2D6 (0.46) SMN1; SMN2RAB9ANPC1MAPTTP53
SCHEMBL24330008 0.78 LRRK2 (0.46) SMN1; SMN2RAB9ANPC1MAPTTP53
SCHEMBL21588444 0.75 RAB9A (0.58) SMN1; SMN2RAB9ANPC1MAPTTP53
SCHEMBL16896300 0.75 KCNH2 (0.62) SMN1; SMN2RAB9ANPC1MAPTTP53
SCHEMBL24359018 0.75 RAB9A (0.66) SMN1; SMN2RAB9ANPC1MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018081612-A1 COMPOUNDS AND METHODS FOR TREATING CANCER ACTAVALON, INC. (US) 2018-05-03 WO disclosed